- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Erik Harris, Elan
S
Erik Harris
Senior Director, Sales and Marketing, Tysabri, Elan
IS BUSY WITH: Newborn twins
BIGGEST ACCOMPLISHMENT: The blockbuster growth of Rituxan
I'm a person that loves challenges," says Erik Harris. And it must be true—otherwise, he wouldn't be heading up the sales and marketing effort for Tysabri and it's new Crohn's Disease indication. "The safety issues, and the fact that patients and doctors have to enroll in a RiskMAP to be on it, make it a difficult product to sell," concedes Harris. "But it's worth it because, for some patients, there are no other options."
Erik Harris
Perhaps even more valuable than his previous work experience building the brands of Rituxan and Tarceva at Genentech, are the lessons Harris learned while serving as a naval aviator for the military. "If you can implement ideas and get people to move forward and change things in that bureaucratic system, well then, those skills translate."
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
